Comparing Two Fluoride Varnishes to Treat Dentin Hypersensitivity in Adults Aged 18 to 40

What this Trial Is About

This trial evaluates the effect of two different fluoride varnish formulations on dentin hypersensitivity DH in young adults diagnosed with this condition. Researchers aim to determine if Clinpro Clear4 aqueous base, 9,500 ppm NaF reduces DH more than Duraphat4 rosinresin base, 22,600 ppm NaF, and whether these treatments improve oral health-related quality of life and patient satisfaction. The study is a randomized controlled clinical trial comparing these two commercially available varnishes. Participants will receive a single application of either Duraphat4 or Clinpro Clear4 under standardized conditions. For Duraphat4, the tooth surface is cleaned, and a thin film is applied with a cotton applicator patients keep lip retractors in place for 15 minutes and avoid brushing or hard foods for 4 hours. For Clinpro Clear4, the tooth is cleaned and dried, varnish is applied with a brush to cover the sensitive area, and patients also keep lip retractors for 15 minutes without disturbing the varnish. During the study, participants will complete baseline and follow-up assessments at 7 and 28 days after application. These include measuring dentin hypersensitivity intensity using a visual analogue scale and Schiff scale, evaluating oral health-related quality of life with the OHIP-14 questionnaire, and assessing patient satisfaction using the CSAT survey. The study runs from baseline through 28 days post-treatment with careful monitoring of outcomes and participant experiences.

Effect of Fluoride Varnish Formulation on the Management of Dentin Hypersensitivity